Dr. Georges-L.-Dumont UHC Biobank will benefit from creation of Atlantic Cancer Consortium

Moncton, Wednesday, August 18, 2021 – The Dr. Georges-L.-Dumont UHC Biobank will benefit from the recent creation of the Atlantic Cancer Consortium (ACC). As an ACC partner, Vitalité Health Network plans to strengthen the relationships of collaboration on cancer research with the other partners from New Brunswick, Nova Scotia and Newfoundland and Labrador. In total, $3.6 million in new funding from provincial and national partners will be invested into research in the Atlantic region.

The ACC will help improve oncology results in the Atlantic region, and the Network will be able to work on the project to create an Atlantic Canada Biobank Consortium (ACBC). “We are thrilled by the creation of the ACC, because we know that this is an important collaboration for progress in precision medicine for patients with cancer,” stated Ms. Stéphanie Crapoulet, the Network’s Biobank Senior Research Coordinator. “We are at an important cancer research junction where we are uniting our strengths to help the public fight this disease. We are proud that our biobank, a true catalyst for fostering research in New Brunswick, is being integrated into this initiative,” she continued.

The Dr. Georges-L.-Dumont UHC Biobank was created in May 2017. The implementation of this Network initiative fits into the development of its university mission. Since its creation, the biobank has implemented several components (tumours, neurological diseases, COVID-19 and cardio-oncology), and it conducts its work in accordance with the highest Canadian and international standards in partnership with the Atlantic Cancer Research Institute (ACRI) with respect to sample processing.

The biobank contains a large number of biological samples and related health data gathered from New Brunswick patients suffering from various pathologies, such as cancer, neurological diseases and COVID-19, and from control subjects. This collection of samples and related data is made available to the scientific community. Researchers whose work focuses on gaining a better understanding of these pathologies may access the clinical data derived from the Dr. Georges-L.-Dumont UHC Biobank.